4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001415889-25-002536
CEO AND PRESIDENT bought 10,040 shares at an average $5.15 ($51,754)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Szela Mary T CEO AND PRESIDENT | 2025-01-29 | Purchase | +5,030 | $5.03 | $25,301 | 439,249 | D |
| Szela Mary T CEO AND PRESIDENT | 2025-01-30 | Purchase | +5,010 | $5.28 | $26,453 | 444,259 | D |
| Open-market purchases · 10,040 sh · avg $5.15 · $51,754 | |||||||
Loading xslF345X05/form4-01312025_100135.xml…